Weight loss alone significantly reduces the burden on the heart, lowering blood pressure, reducing harmful LDL cholesterol, and improving triglyceride levels
Some patients require doses in the 1.02.4 mg range to see meaningful results, while others respond at 0.5 mg
Tirzepatide: What Are They
PIONEER 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes
In December 2024, a phase IIa dose-ranging trial (NCT06717425 ) to investigate this drug began, and is due to end in December 2025 5
Berberine was found to be just as effective at reducing blood glucose as Metformin, another diabetes drug, in a triple-blind clinical trial of over 200 participants (2)